Cyto-Pathology Classification
Phenotype Mixed phenotype acute leukaemia, T/myeloid, NOS Immunophenotype Positve for CD2,cyCD3,CD7,CD13,CD15,CD34,HLA-DR, and dimly positive for CD33,MPO,TdT. Negative for CD1a,CD5,CD11b,CD117,TCR-AB,TCR-GD Rearranged Ig Tcr Not performed. Pathology Acute leukemia compatible. Electron microscopy Not performed.
Diagnosis
Mixed phenotype acute leukemia, T/myeloid, NOS. Figure 2a .
Other molecular cytogenetics results
Negative for immunoglobulin heavy chain (IgH) translocation (Figure 2b ).
Other Molecular Studies
Technics:
Polymerase chain reaction (PCR) and Sanger sequencing Results:
Positive for Flt3-internal tandem duplication(ITD). Negative for c-kit mutation.
Partial karyotype from bone marrow cells at the time of diagnosis showing the chromosomal translocation t(6;14)(q25;q32). 
Comments
We present an adult case of biphenotypic acute leukemia with t(6;14)(q25;q32). Chromosome translocations involving 14q32 are generally represented by B cell neoplasms, because the immunoglobulin heavy chain (IgH) gene is located in this region. However, BCL11B gene also located in 14q32 was shown to be involved in this translocation (Bezrookove et al.,2004) . BCL11B, a member of the Kruppel family of zinc finger trascription factors, plays a critical role in T cell development and functions as a tumor suppressor . The partner gene of this translocation is unknown. The 28S ribosomal DNA (RN28S1) was reported as a candidate fusion partner (Kobayashi et al.,2014) , but this gene is not located in 6q25. The phenotype of haematological malignancies with t(6;14)(q25;q32) is variable. These include acute lymphoblastic leukemia (ALL) (Heerema et al.,2002) , mixed phenotype acute leukemia (Hayashi et al.,1990 , Batanian et al.,1996 , Georgy et al.,2008 , Kobayashi et al.,2014 , acute myeloid leukaemia (AML) (Raimondi et al.,1989 , Bezrookove et al.,2004 , chronic T cell neoplasm (Inwards et al.,1990) and chronic lymphocytic leukaemia (CLL) (Mayr et al.,2006) . In 7 of 9 acute leukaemia cases with this translocation, both myeloid and T-cell lineage markers were detected. No immunophenotype was described in the remaining two cases. This translocation may affect expression of T-cell lineage marker, but the role of BCL11B is unclear.
